BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 5:55:00 PM | Browse: 1193 | Download: 1133
 |
Received |
|
2012-11-27 14:08 |
 |
Peer-Review Started |
|
2012-11-28 15:34 |
 |
To Make the First Decision |
|
2012-12-13 12:33 |
 |
Return for Revision |
|
2012-12-13 17:30 |
 |
Revised |
|
2013-05-22 14:23 |
 |
Second Decision |
|
2013-08-29 07:53 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2013-08-29 09:50 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-09-17 09:12 |
 |
Publish the Manuscript Online |
|
2013-10-31 14:50 |
Category |
Radiology, Nuclear Medicine & Medical Imaging |
Manuscript Type |
Frontier |
Article Title |
New insights for pelvic radiation disease treatment: Multipotent stromal cell is a promise mainstay treatment for the restoration of abdominopelvic severe chronic damages induced by radiotherapy
|
Manuscript Source |
Invited Manuscript |
All Author List |
Alain Chapel, Sabine Francois, Luc Douay, Marc Benderitter and Jan Voswinkel |
Funding Agency and Grant Number |
|
Corresponding Author |
Alain Chapel, PhD, Radiological Protection and Human Health Division, Institute of Radiological Protection and Nuclear Safety, PRP-HOM/SRBE/Laboratory of Radiopathology and Experimental Therapy, BP17, 92262 Fontenay-aux-Roses, France. alain.chapel@irsn.fr |
Key Words |
Cell therapy; Radiotherapy; Irradiation; Stem cells; Multipotent stromal cells; Mesenchymal stem cells; Clinical trial |
Core Tip |
Multipotent stromal cells (MSCs) provide a long-term effect in inhibition of chronic inflammation and a fistulisation, arrest of hemorrhagic syndromes for the hemorrhagic cystitis. MSCs are successfully used to treat the late effects of radiotherapies for breast cancer and radiodermatitis. Their efficiency was also demonstrated on pain reduction. Concerning clinical trials to cure abdominal late severe damages of radiotherapy, one compassionate trial has demonstrated the feasibility of cell therapy treatment for patients overdosed. |
Publish Date |
2013-10-31 14:50 |
Citation |
Chapel A, Francois S, Douay L, Benderitter M, Voswinkel J. New insights for pelvic radiation disease treatment: Multipotent stromal cell is a promise mainstay treatment for the restoration of abdominopelvic severe chronic damages induced by radiotherapy. World J Stem Cells 2013; 5(4): 106-111 |
URL |
http://www.wjgnet.com/1948-0210/full/v5/i4/106.htm |
DOI |
http://dx.doi.org/10.4252/wjsc.v5.i4.106 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345